Michal B Juda1, Alexandra K Brooks2, Albert E Towers3, Gregory G Freund1,3,4, Robert H McCusker1,2,4, Andrew J Steelman1,2,3. 1. Department of Animal Sciences, College of Agricultural, Consumer, and Environmental Sciences, Urbana, Illinois. 2. Neuroscience Program, College of Medicine, University of Illinois Urbana-Champaign, Urbana, Illinois. 3. Division of Nutritional Sciences, College of Medicine, University of Illinois Urbana-Champaign, Urbana, Illinois. 4. Department of Pathology, College of Medicine, University of Illinois Urbana-Champaign, Urbana, Illinois.
Abstract
OBJECTIVE: Viral encephalitis increases the risk for developing seizures and epilepsy. Indoleamine 2,3-dioxygenase 1 (Ido1) is induced by inflammatory cytokines and functions to metabolize tryptophan to kynurenine. Kynurenine can be further metabolized to produce kynurenic acid and the N-methyl-d-aspartate receptor agonist quinolinic acid (QuinA). In the present study, we sought to determine the role of Ido1 in promoting seizures in an animal model of viral encephalitis. METHODS: C57BL/6J and Ido1 knockout mice (Ido1-KO) were infected with Theiler's murine encephalomyelitis virus (TMEV). Quantitative real-time polymerase chain reaction was used to evaluate hippocampal expression of proinflammatory cytokines, Ido1, and viral RNA. Body weights and seizure scores were recorded daily. Elevated zero maze was used to assess differences in behavior, and hippocampal pathology was determined by immunohistochemistry. RESULTS: Infected C57BL/6J mice up-regulated proinflammatory cytokines, Ido1, and genes encoding the enzymatic cascade responsible for QuinA production in the kynurenine pathway prior to the onset of seizures. Seizure incidence was elevated in Ido1-KO compared to C57BL/6J mice. Infection increased locomotor activity in Ido1-KO compared to C57BL/6J mice. Furthermore, the occurrence of seizures was associated with hyperexcitability. Neither expression of proinflammatory cytokines nor viral RNA was altered as a result of genotype. Immunohistochemical analysis revealed increased hippocampal pathology in Ido1-KO mice. SIGNIFICANCE: Our findings suggest that Ido1 deletion promotes seizures and neuropathogenesis during acute TMEV encephalitis. Wiley Periodicals, Inc.
OBJECTIVE:Viral encephalitis increases the risk for developing seizures and epilepsy. Indoleamine 2,3-dioxygenase 1 (Ido1) is induced by inflammatory cytokines and functions to metabolize tryptophan to kynurenine. Kynurenine can be further metabolized to produce kynurenic acid and the N-methyl-d-aspartate receptor agonist quinolinic acid (QuinA). In the present study, we sought to determine the role of Ido1 in promoting seizures in an animal model of viral encephalitis. METHODS: C57BL/6J and Ido1 knockout mice (Ido1-KO) were infected with Theiler's murine encephalomyelitis virus (TMEV). Quantitative real-time polymerase chain reaction was used to evaluate hippocampal expression of proinflammatory cytokines, Ido1, and viral RNA. Body weights and seizure scores were recorded daily. Elevated zero maze was used to assess differences in behavior, and hippocampal pathology was determined by immunohistochemistry. RESULTS:Infected C57BL/6J mice up-regulated proinflammatory cytokines, Ido1, and genes encoding the enzymatic cascade responsible for QuinA production in the kynurenine pathway prior to the onset of seizures. Seizure incidence was elevated in Ido1-KO compared to C57BL/6J mice. Infection increased locomotor activity in Ido1-KO compared to C57BL/6J mice. Furthermore, the occurrence of seizures was associated with hyperexcitability. Neither expression of proinflammatory cytokines nor viral RNA was altered as a result of genotype. Immunohistochemical analysis revealed increased hippocampal pathology in Ido1-KO mice. SIGNIFICANCE: Our findings suggest that Ido1 deletion promotes seizures and neuropathogenesis during acute TMEV encephalitis. Wiley Periodicals, Inc.
Authors: Andrew J Steelman; Dana D Dean; Colin R Young; Roger Smith; Thomas W Prentice; Mary W Meagher; C Jane R Welsh Journal: Brain Behav Immun Date: 2009-04-05 Impact factor: 7.217
Authors: Eleonora Aronica; Sebastian Bauer; Yuri Bozzi; Matteo Caleo; Raymond Dingledine; Jan A Gorter; David C Henshall; Daniela Kaufer; Sookyong Koh; Wolfgang Löscher; Jean-Pierre Louboutin; Michele Mishto; Braxton A Norwood; Eleonora Palma; Michael O Poulter; Gaetano Terrone; Annamaria Vezzani; Rafal M Kaminski Journal: Epilepsia Date: 2017-07 Impact factor: 5.864
Authors: Jane E Libbey; Nikki J Kirkman; Matthew C P Smith; Tomoko Tanaka; Karen S Wilcox; H Steve White; Robert S Fujinami Journal: Epilepsia Date: 2008-03-06 Impact factor: 5.864
Authors: Candice L Brinkmeyer-Langford; Raquel Rech; Katia Amstalden; Kelli J Kochan; Andrew E Hillhouse; Colin Young; C Jane Welsh; David W Threadgill Journal: Sci Rep Date: 2017-09-22 Impact factor: 4.379